Literature DB >> 33062911

Subthreshold Exudative Choroidal Neovascularization Associated With Age-Related Macular Degeneration Identified by Optical Coherence Tomography Angiography.

Miin Roh1,2, Joan W Miller1, Karen W Jeng-Miller1, Jay C Wang1, Inês Laíns1, Rebecca F Silverman1, John I Loewenstein1, Deeba Husain1, Demetrios G Vavvas1, John B Miller1.   

Abstract

PURPOSE: This article describes the clinical and multimodal imaging characteristics of subthreshold exudative choroidal neovascularization (CNV) associated with age-related macular degeneration (AMD).
METHODS: Among 3773 patients with AMD, 8 eyes (6 patients) were identified with the clinical phenotype of interest. Dilated fundus examinations, color fundus photography, fluorescein angiography (FA), indocyanine green angiography (ICGA), optical coherence tomography (OCT), and OCT angiography (OCTA) were performed.
RESULTS: OCT typically showed a moderately reflective irregular pigment epithelial detachment with overlying subretinal fluid (SRF). Traditional FA did not show leakage and ICGA showed no definitive neovascular network or hot spots. However, OCTA clearly demonstrated a CNV within the pigment epithelial detachment. The majority of our cases (7 of 8) did not receive antivascular endothelial growth factor (anti-VEGF) injections, and visual acuity remained stable over the available follow-up period of I to 10 years.
CONCLUSIONS: CNV is often associated with SRF and vision loss in AMD, usually requiring frequent anti-VEGF injections. OCTA allowed us to better identify CNV not readily detected on FA and ICGA. Although some have suggested early clinical intervention with anti-VEGF injections in any case with fluid and confirmed CNV on OCTA, we describe a subset of AMD patients with SRF who may be better managed by observation. These cases may represent a more indolent, mature, and stable vascular network.

Entities:  

Keywords:  age-related macular degeneration; choroidal neovascularization; optical coherence tomography angiography

Year:  2020        PMID: 33062911      PMCID: PMC7556719          DOI: 10.1177/2474126420916607

Source DB:  PubMed          Journal:  J Vitreoretin Dis        ISSN: 2474-1264


  26 in total

1.  Spectral-domain optical coherence tomography as an indicator of fluorescein angiography leakage from choroidal neovascularization.

Authors:  Andrea Giani; Cristiano Luiselli; Daniel D Esmaili; Paola Salvetti; Mario Cigada; Joan W Miller; Giovanni Staurenghi
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-29       Impact factor: 4.799

2.  Occult with no classic subfoveal choroidal neovascular lesions in age-related macular degeneration: clinically relevant natural history information in larger lesions with good vision from the Verteporfin in Photodynamic Therapy (VIP) Trial: VIP Report No. 4.

Authors:  Dante J Pieramici; Susan B Bressler; John M Koester; Neil M Bressler
Journal:  Arch Ophthalmol       Date:  2006-05

3.  Indocyanine green angiography of choroidal neovascular membranes.

Authors:  K Hayashi; J J de Laey
Journal:  Ophthalmologica       Date:  1985       Impact factor: 3.250

4.  [Photodynamic therapy in "Secondary Sick RPE Syndrome" after repeated intravitreal injections of VEGF inhibitors in patients with wet age-related macular degeneration].

Authors:  P Kloos; H Niederberger; C Valmaggia
Journal:  Klin Monbl Augenheilkd       Date:  2011-04-11       Impact factor: 0.700

5.  OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY VERSUS TRADITIONAL MULTIMODAL IMAGING IN ASSESSING THE ACTIVITY OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION: A New Diagnostic Challenge.

Authors:  Gabriel J Coscas; Marco Lupidi; Florence Coscas; Carlo Cagini; Eric H Souied
Journal:  Retina       Date:  2015-11       Impact factor: 4.256

6.  Optical Coherence Tomography Angiography of Asymptomatic Neovascularization in Intermediate Age-Related Macular Degeneration.

Authors:  Luiz Roisman; Qinqin Zhang; Ruikang K Wang; Giovanni Gregori; Anqi Zhang; Chieh-Li Chen; Mary K Durbin; Lin An; Paul F Stetson; Gillian Robbins; Andrew Miller; Fang Zheng; Philip J Rosenfeld
Journal:  Ophthalmology       Date:  2016-02-12       Impact factor: 12.079

7.  Optical Coherence Tomography Angiography Imaging of Quiescent Choroidal Neovascularization in Age-Related Macular Degeneration.

Authors:  Márcio B Nehemy; Daniel N Brocchi; Carlos E Veloso
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2015 Nov-Dec       Impact factor: 1.300

8.  Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2.

Authors:  Irene Barbazetto; Amy Burdan; Neil M Bressler; Susan B Bressler; Laurie Haynes; Anastasios D Kapetanios; Julius Lukas; Karl Olsen; Michael Potter; Al Reaves; Philip Rosenfeld; Andrew P Schachat; H Andrew Strong; Andrea Wenkstern
Journal:  Arch Ophthalmol       Date:  2003-09

9.  Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Macular Photocoagulation Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1996-04

10.  Natural History of Subclinical Neovascularization in Nonexudative Age-Related Macular Degeneration Using Swept-Source OCT Angiography.

Authors:  João R de Oliveira Dias; Qinqin Zhang; José M B Garcia; Fang Zheng; Elie H Motulsky; Luiz Roisman; Andrew Miller; Chieh-Li Chen; Sophie Kubach; Luis de Sisternes; Mary K Durbin; William Feuer; Ruikang K Wang; Giovanni Gregori; Philip J Rosenfeld
Journal:  Ophthalmology       Date:  2017-09-28       Impact factor: 12.079

View more
  2 in total

Review 1.  Age-related macular degeneration.

Authors:  Monika Fleckenstein; Tiarnán D L Keenan; Robyn H Guymer; Usha Chakravarthy; Steffen Schmitz-Valckenberg; Caroline C Klaver; Wai T Wong; Emily Y Chew
Journal:  Nat Rev Dis Primers       Date:  2021-05-06       Impact factor: 52.329

Review 2.  Subthreshold Exudative Choroidal Neovascularization (CNV): Presentation of This Uncommon Subtype and Other CNVs in Age-Related Macular Degeneration (AMD).

Authors:  Vivian Paraskevi Douglas; Itika Garg; Konstantinos A A Douglas; John B Miller
Journal:  J Clin Med       Date:  2022-04-07       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.